Clinical Trials Browser

Neoplasms × Drug Therapy × 90 days × Clear all

NCT07022483 2026-02-04

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

Phase 3 Recruiting

Neoplasms, Endometrial Neoplasms

NCT05421897 2026-01-29

RAPID

Phase 1 Active not recruiting

Neoplasms, Neuroblastoma